Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Dec 1, 2015

Accelerate Diagnostics to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
TUCSON, Ariz., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update at the Piper Jaffray Healthcare Conference in New York City, NY on Wednesday, December 2nd at 12:30 PM ET. About Accelerate Diagnostics, Inc. ...Read more

Aug 5, 2015

Accelerate Diagnostics to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015
TUCSON, Ariz., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update ...Read more

Jun 30, 2015

Accelerate Diagnostics Achieves CE-IVD Milestone for ID/AST System and ID/AST Blood Culture Assay
TUCSON, Ariz., June 30, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC and CE Mark of the Accelerate ID/AST System and ID/AST Blood Culture Assay for in vitro diagnostic use. The Accelerate ID/AST System is a diagnostic platform providing ra...Read more

Apr 17, 2015

Accelerate Diagnostics Announces New Leadership Appointments
TUCSON, Ariz., April 17, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant organisms, announced today that it has appointed Ron Price as Senior Vice President and Head of Commercial Operations for the Americas. Mr. Price will repla...Read more

Mar 23, 2015

Accelerate Diagnostics Names Juan Martin as Head of Europe, Middle East and Africa
TUCSON, Ariz., March 23, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant organisms, announced today that it has named Juan Martin as Executive Vice President and Head of Europe, Middle East and Africa (EMEA). Martin bring...Read more

Mar 16, 2015

Accelerate Diagnostics Achieves ISO 13485 Certification and Initial Installations of Accelerate ID/AST System
TUCSON, Ariz., March 16, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant organisms, announced today that it received ISO 13485:2003 certification for its quality management system and began manufacturing and install...Read more

Jan 7, 2015

Accelerate Diagnostics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
TUCSON, Ariz., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update ...Read more

Nov 3, 2014

Accelerate Diagnostics Announces Research Collaboration With CDC Laboratory for Early Detection of Antibiotic-Resistant Biothreat Agents
TUCSON, Ariz., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today announced that it has entered into a research collaboration with the Rapid Antimicrobial Susceptibility Testing Laboratory at the U.S...Read more

Sep 25, 2014

Accelerate Diagnostics Supports Drug Stewardship and Early Detection in The President's Initiative to Combat Antibiotic-Resistant Bacteria
TUCSON, Ariz., Sept. 25, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today commended the Obama Administration's actions to combat antibiotic-resistant bacteria, and underscored two areas of critical importa...Read more

May 2, 2014

Accelerate Diagnostics Announces Final Results of Rights Offering
TUCSON, Ariz., May 2, 2014 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), announced today that it has completed its previously announced rights offering. Through broad participation from both insiders and non-insider investors, together with funds committed through the related standby commitments, the company raised $45,000,000 from t...Read more

= add release to Briefcase
NASDAQ: AXDX
$ 22.88
+0.13
(0.59%)
9:38 AM ET on Mar 24, 2017
Day High: 22.91
Day Low:  22.75
Volume:    3,859
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates